Form 4: Edgewell Personal Care Executive Jessica Spence Acquires Restricted Stock Equivalents

Sentiment:

SEC Form 4 Filing


Jessica Spence, President of North America at Edgewell Personal Care, acquired 13,275 restricted stock equivalents, which will vest over the next three years.

Summary

  • Jessica Spence, President of North America at Edgewell Personal Care, has reported the acquisition of 13,275 restricted stock equivalents (RSEs).
  • These RSEs were granted on November 8, 2024, at a price of $0.
  • The RSEs will vest in three equal installments on November 8, 2025, November 8, 2026, and November 8, 2027, contingent upon Ms. Spence's continued employment.
  • The RSEs will convert into shares of Edgewell common stock upon vesting.
  • The vesting may also occur upon death, disability, change in control, or certain termination events.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.

Positives

  • The grant of restricted stock equivalents to a key executive like Jessica Spence aligns her interests with the long-term performance of the company.
  • The vesting schedule encourages continued employment and commitment from the executive.

Risks

  • The vesting of the RSEs is contingent upon continued employment, which could be a risk if the executive were to leave the company before the vesting dates.

Future Outlook

The restricted stock equivalents will vest over the next three years, contingent on continued employment.

Industry Context

This type of equity grant is a common practice for incentivizing and retaining key executives in publicly traded companies.

Comparison to Industry Standards

  • Granting restricted stock equivalents is a standard practice for executive compensation across various industries, including consumer goods.
  • The vesting schedule of three years is also a common timeframe to ensure long-term commitment from executives.
  • Companies like Procter & Gamble and Unilever also use similar equity-based compensation plans for their executives.

Stakeholder Impact

  • The grant of RSEs to a key executive can be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
  • Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
11/08/2024Date of the transaction and grant of restricted stock equivalents.
11/08/2025First vesting date for one-third of the restricted stock equivalents.
11/08/2026Second vesting date for one-third of the restricted stock equivalents.
11/08/2027Final vesting date for one-third of the restricted stock equivalents.
11/12/2024Date of signature of the form.

Keywords

restricted stock equivalents, RSE, insider trading, executive compensation, equity, Edgewell Personal Care, Jessica Spence

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.